Generation of mice with a conditional allele for transforming growth factor beta 1 gene

Genesis

Volumn 47, Issue 6, 2009, Pages 423-431

  Azhar, Mohamad ^a,h   Yin, Moying ^b   Bommireddy, Ramireddy ^a,c   Duffy, John J ^b   Yang, Junqi ^b   Pawlowski, Sharon A ^b   Boivin, Gregory P ^b   Engle, Sandra J ^d   Sanford, L P ^a   Grisham, Christina ^b   Singh, Ram R ^e   Babcock, George F ^f,g   Doetschman, Thomas ^a,h  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d PFIZER INC   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CINCINNATI   (United States)

^g SHRINERS HOSPITALS FOR CHILDREN   (United States)

^h NONE   (United States)

Author keywords

Conditional knockout mice; Transforming growth factor

Indexed keywords

CRE RECOMBINASE; PROTEIN KINASE LCK; TRANSFORMING GROWTH FACTOR BETA1;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CLONING; CONTROLLED STUDY; CROSS BREEDING; EXON; GENE DELETION; GENE DISRUPTION; HOMEOSTASIS; IMMUNOREGULATION; KNOCKOUT MOUSE; LOXP SITE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ALLELES; ANIMALS; CELL COUNT; EXONS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE TARGETING; HOMEOSTASIS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, KNOCKOUT; MICE, TRANSGENIC; MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLEEN; T-LYMPHOCYTES; THYMUS GLAND; TRANSFORMING GROWTH FACTOR BETA1;

MUS; MUS MUSCULUS;

EID: 70349171864     PISSN: 1526954X     EISSN: 1526968X     Source Type: Journal    
DOI: 10.1002/dvg.20516     Document Type: Article

References (31)

1. Azhar M, Schultz JE, Grupp I, Dorn GW, Meneton P, Molin DG, Gittenberger-de Groot AC, Doetschman T. 2003. Transforming growth factor beta in cardiovascular development and function. Cytokine Growth Factor Rev 14:391-407.
2. Azhar M, Yin M, Zhou M, Li H, Mustafa M, Nusayr E, Keenan JB, Chen H, Pawlosky S, Gard C, Grisham C, Sanford LP, Doetschman T. 2008. Gene targeted ablation of high molecular weight fibroblast growth factor-2. Dev Dyn 238:351-357.
3. Bommireddy R, Doetschman T. 2007. TGFbeta1 and T(reg) cells: Alliance for tolerance. Trends Mol Med 13:492-501.
4. 2+-Calcineurin-mediated activation in thymocytes. J Immunol 170:3645-3652.
5. Bommireddy R, Saxena V, Ormsby I, Yin M, Boivin GP, Babcock GF, Singh RR, Doetschman T. 2003b. TGF-beta1 regulates lymphocyte homeostasis by preventing activation and subsequent apoptosis of peripheral lymphocytes. J Immunol 170:4612-4622.
6. Derynck R, Akhurst RJ. 2007. Differentiation plasticity regulated by TGF-beta family proteins in development and disease. Nat Cell Biol 9:1000-1004.
7. Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S, Akhurst RJ. 1995. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development 121:1845-1854.
8. Engle SJ, Hoying JB, Boivin GP, Ormsby I, Gartside PS, Doetschman T. 1999. Transforming growth factor beta1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis. Cancer Res 59:3379-3386.
9. Kaartinen V, Voncken JW, Shuler C, Warburton D, Bu D, Heisterkamp N, Groffen J. 1995. Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nat Genet 11:415-421.
10. Kehrl JH, Wakefield LM, Roberts AB, Jakowlew S, Alvarez-Mon M, Derynck R, Sporn MB, Fauci AS. 1986. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 163:1037-1050.
11. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, Karlsson S. 1993. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 90:770-774.
12. Leveen P, Carlsen M, White-Makowska A, Oddsson S, Larsson J, Goumans MJ, Cilio CM, Karlsson S. 2005. TGF-{beta} type II receptor deficient thymocytes develop normally but demonstrate increased CD8+ proliferation in vivo. Blood 106:4234-4240.
13. Li MO, Flavell RA. 2008. TGF-beta: A master of all T cell trades. Cell 134:392-404.
14. Li MO, Wan YY, Flavell RA. 2007. T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 26:579-591.
15. Longenecker G, Thyagarajan T, Nagineni CN, Flanders KC, Factor V, Miller G, Ward JM, Nalca A, Rangnekar VM, Thorgeirsson S, Kulkarni AB. 2002. Endocrine expression of the active form of TGF-beta1 in the TGF-beta1 null mice fails to ameliorate lethal phenotype. Cytokine 18:43-50.
16. Lucas PJ, Kim SJ, Melby SJ, Gress RE. 2000. Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor beta II receptor. J Exp Med 191: 1187-1196.
17. Marie JC, Letterio JJ, Gavin M, Rudensky AY. 2005. TGF-{beta}1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J Exp Med 201:1061-1067.
18. Massague J, Gomis RR. 2006. The logic of TGFbeta signaling. FEBS Lett 580:2811-2820.
19. McLennan IS, Koishi K. 2002. The transforming growth factor-betas: Multifaceted regulators of the development and maintenance of skeletal muscles, motoneurons and Schwann cells. Int J Dev Biol 46:559-567.
20. Millan FA, Denhez F, Kondaiah P, Akhurst RJ. 1991. Embryonic gene expression patterns of TGF beta 1, beta 2 and beta 3 suggest different developmental functions in vivo. Development 111:131-143.
21. Orban PC, Chui D, Marth JD. 1992. Tissue- and site-specific DNA recombination in transgenic mice. Proc Natl Acad Sci USA 89: 6861-6865.
22. Pelton RW, Saxena B, Jones M, Moses HL, Gold LI. 1991. Immunohistochemical localization of TGF beta 1. TGF beta 2, and TGF beta 3 in the mouse embryo: Expression patterns suggest multiple roles during embryonic development. J Cell Biol 115:1091-1105.
23. Proetzel G, Pawlowski SA, Wiles MV, Yin M, Boivin GP, Howles PN, Ding J, Ferguson MW, Doetschman T. 1995. Transforming growth factor-beta 3 is required for secondary palate fusion. Nat Genet 11:409-414.
24. Rajan S, Williams SS, Jagatheesan G, Ahmed RP, Fuller-Bicer G, Schwartz A, Aronow BJ, Wieczorek DF. 2006. Microarray analysis of gene expression during early stages of mild and severe cardiac hypertrophy. Physiol Genom 27:309-317.
25. Robinson RT, Gorham JD. 2007. TGF-beta 1 regulates antigen-specific CD4+ T cell responses in the periphery. J Immunol 179:71-79.
26. Sanford LP, Ormsby I, Gittenberger-de GA, Sariola H, Friedman R, Boivin GP, Cardell EL, Doetschman T. 1997. TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development 124: 2659-2670.
27. Saxena V, Lienesch DW, Zhou M, Bommireddy R, Azhar M, Doetschman T, Singh RR. 2008. Dual roles of immunoregulatory cytokine TGF-{beta} in the pathogenesis of autoimmunity-mediated organ damage. J Immunol 180:1903-1912.
28. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Doetschman T. 1992. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359:693-699.
29. Sporn MB. 2006. The early history of TGF-beta, and a brief glimpse of its future. Cytokine Growth Factor Rev 17:3-7.
30. Thompson NL, Flanders KC, Smith JM, Ellingsworth LR, Roberts AB, Sporn MB. 1989. Expression of transforming growth factor-beta 1 in specific cells and tissues of adult and neonatal mice. J Cell Biol 108:661-669.
31. Yang Z, Mu Z, Dabovic B, Jurukovski V, Yu D, Sung J, Xiong X, Munger JS. 2007. Absence of integrin-mediated TGFbeta1 activation in vivo recapitulates the phenotype of TGFbeta1-null mice. J Cell Biol 176:787-793.